These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26907633)

  • 1. MUC1-C drives MYC in multiple myeloma.
    Tagde A; Rajabi H; Bouillez A; Alam M; Gali R; Bailey S; Tai YT; Hideshima T; Anderson K; Avigan D; Kufe D
    Blood; 2016 May; 127(21):2587-97. PubMed ID: 26907633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
    Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
    Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1-C activates BMI1 in human cancer cells.
    Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
    Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1-C is a target in lenalidomide resistant multiple myeloma.
    Yin L; Tagde A; Gali R; Tai YT; Hideshima T; Anderson K; Avigan D; Kufe D
    Br J Haematol; 2017 Sep; 178(6):914-926. PubMed ID: 28643330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma.
    Tagde A; Markert T; Rajabi H; Hiraki M; Alam M; Bouillez A; Avigan D; Anderson K; Kufe D
    Oncotarget; 2017 Sep; 8(41):69237-69249. PubMed ID: 29050200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH.
    Yin L; Kosugi M; Kufe D
    Blood; 2012 Jan; 119(3):810-6. PubMed ID: 22117045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
    Rajabi H; Ahmad R; Jin C; Kosugi M; Alam M; Joshi MD; Kufe D
    J Biol Chem; 2012 Mar; 287(13):10703-10713. PubMed ID: 22318732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 oncoprotein promotes growth and survival of human multiple myeloma cells.
    Kawano T; Ahmad R; Nogi H; Agata N; Anderson K; Kufe D
    Int J Oncol; 2008 Jul; 33(1):153-9. PubMed ID: 18575761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
    Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
    Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of mucin 1 inhibits progression of colon carcinoma by repression of Wnt/β-catenin signaling.
    Wang Z; Sun J; Hu X; Huang S
    DNA Cell Biol; 2014 Mar; 33(3):162-70. PubMed ID: 24410135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7.
    Li Y; Chen W; Ren J; Yu WH; Li Q; Yoshida K; Kufe D
    Cancer Biol Ther; 2003; 2(2):187-93. PubMed ID: 12750561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
    Yochum GS; Cleland R; Goodman RH
    Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival.
    Bommert KS; Effenberger M; Leich E; Küspert M; Murphy D; Langer C; Moll R; Janz S; Mottok A; Weissbach S; Rosenwald A; Bargou R; Bommert K
    Leukemia; 2013 Feb; 27(2):441-50. PubMed ID: 22772059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth.
    Fulciniti M; Amodio N; Bandi RL; Cagnetta A; Samur MK; Acharya C; Prabhala R; D'Aquila P; Bellizzi D; Passarino G; Adamia S; Neri A; Hunter ZR; Treon SP; Anderson KC; Tassone P; Munshi NC
    Blood Cancer J; 2016 Jan; 6(1):e380. PubMed ID: 26771806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.
    Xu J; Chen Y; Huo D; Khramtsov A; Khramtsova G; Zhang C; Goss KH; Olopade OI
    Mol Carcinog; 2016 May; 55(5):431-9. PubMed ID: 25663530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human full-length MUC1 inhibits the proliferation and migration of a B16 mouse melanoma cell line.
    Wang F; Li Q; Ni W; Fang F; Sun X; Xie F; Wang J; Wang F; Gao S; Tai G
    Oncol Rep; 2013 Jul; 30(1):260-8. PubMed ID: 23633115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.
    Lillehoj EP; Lu W; Kiser T; Goldblum SE; Kim KC
    Biochim Biophys Acta; 2007 Jul; 1773(7):1028-38. PubMed ID: 17524503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.